Tracking MG symptoms after starting VYVGART
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study uses a smartphone app (BioDigit MG) to monitor how your myasthenia gravis symptoms change after you start treatment with VYVGART or VYVGART Hytrulo. It aims to see if the app can reliably measure disease activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have generalized myasthenia gravis (gMG) – meaning symptoms affect more than just your eyes, like your arms, legs, or breathing.
- Your MG is moderate to severe (MGFA class II, III, or IV) at the screening visit.
- You are about to start or have just started treatment with VYVGART or VYVGART Hytrulo.
- You can walk at least 10 meters (about 33 feet) on your own, with or without a cane or walker.
- You can read and speak English well enough to use the study app.
- You do not need help with daily tasks like dressing, bathing, or eating.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses wearable sensors and smartphone apps to track your myasthenia gravis symptoms over time. It aims to see how well these technologies can measure your condition in daily life, which could help you and your doctor manage your care better.
This trial uses a smartphone app and an activity tracker to remotely monitor symptoms of generalized myasthenia gravis (gMG). It aims to improve how doctors track your condition from home.
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
This study tests whether remote monitoring through smartphone apps can effectively track myasthenia gravis symptoms and help manage care from home, instead of frequent in-person visits.
This study uses your smartphone to record symptoms like slurred speech, hoarseness, arm fatigue, or droopy eyelids, making it easier for doctors to understand and monitor myasthenia gravis. Both people with MG and healthy volunteers can take part.
This trial tests multiple treatment combinations for people with myasthenia gravis (MG), a condition that causes muscle weakness. It aims to find safer and more effective options by comparing different therapies.
Hear when a new Myasthenia Gravis Generalized trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.